Directly monitoring the dynamic in vivo metabolisms of hyperpolarized 13 C-oligopeptides
Yohei Kondo,Yutaro Saito,Tomohiro Seki,Yoichi Takakusagi,Norikazu Koyasu,Keita Saito,Jumpei Morimoto,Hiroshi Nonaka,Koichiro Miyanishi,Wataru Mizukami,Makoto Negoro,Abdelazim E. Elhelaly,Fuminori Hyodo,Masayuki Matsuo,Natarajan Raju,Rolf E. Swenson,Murali C. Krishna,Kazutoshi Yamamoto,Shinsuke Sando
DOI: https://doi.org/10.1126/sciadv.adp2533
IF: 13.6
2024-10-18
Science Advances
Abstract:Peptides play essential roles in biological phenomena, and, thus, there is a growing interest in detecting in vivo dynamics of peptide metabolisms. Dissolution-dynamic nuclear polarization (d-DNP) is a state-of-the-art technology that can markedly enhance the sensitivity of nuclear magnetic resonance (NMR), providing metabolic and physiological information in vivo. However, the hyperpolarized state exponentially decays back to the thermal equilibrium, depending on the spin-lattice relaxation time ( T 1 ). Because of the limitation in T 1 , peptide-based DNP NMR molecular probes applicable in vivo have been limited to amino acids or dipeptides. Here, we report the direct detection of in vivo metabolic conversions of hyperpolarized 13 C-oligopeptides. Structure-based T 1 relaxation analysis suggests that the C-terminal [1- 13 C]Gly- d 2 residue affords sufficient T 1 for biological uses, even in relatively large oligopeptides, and allowed us to develop 13 C-β-casomorphin-5 and 13 C-glutathione. It was found that the metabolic response and perfusion of the hyperpolarized 13 C-glutathione in the mouse kidney were significantly altered in a model of cisplatin-induced acute kidney injury.
multidisciplinary sciences